Entry Detail



General Information

Database ID:exR0000286
RNA Name:ADCY3
RNA Type:mRNA
Chromosome:chr2
Starnd:-
Coordinate:
Start Site(bp):24819169End Site(bp):24919839
External Links:ENSG00000138031



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
COL4A5
chrX
108439844
108697545
+
GPC3
chrX
133535745
133985594
-
ERCC2
chr19
45349837
45370918
-
HNRNPL
chr19
38836388
38852347
-
GMPR
chr6
16238587
16295549
+
MED12
chrX
71118556
71142454
+
PIEZO2
chr18
10666483
11148762
-
PIP5K1C
chr19
3630183
3700479
-
MTRR
chr5
7851186
7906025
+
IMP4
chr2
130342877
130347967
+
PEX2
chr8
76980258
77001044
-
RPL4
chr15
66498015
66524532
-
CCDC47
chr17
63745255
63776351
-
HIGD1A
chr3
42784298
42804531
-
CYTH1
chr17
78674048
78782297
-
MSC
chr8
71841549
71844468
-
LCOR
chr10
96832282
96995959
+
KIF1A
chr2
240713761
240821036
-
SESN3
chr11
95165513
95232541
-
RHOC
chr1
112701106
112707434
-
WDR81
chr17
1716523
1738599
+
FAM8A1
chr6
17600302
17611715
+
RAN
chr12
130872037
130877678
+
ANO8
chr19
17323223
17334855
-
AKT2
chr19
40230317
40285536
-
POTEF
chr2
130073535
130129222
-
GNB1
chr1
1785285
1891117
-
PIH1D1
chr19
49446298
49453497
-
NFE2L1
chr17
48048329
48061545
+
AL049629.2
chr11
33698261
33722467
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-367-3p
chr4
112647877
112647898
-
hsa-miR-92b-3p
chr1
155195237
155195258
+
hsa-miR-155-3p
chr21
25574022
25574043
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC073062.1
chr2
13537673
13609168
+
AC099329.1
chr3
42785087
42852428
-
AL160408.3
chr1
234669523
234696153
-
LINC01866
chr2
16970034
16974497
+
MEF2C-AS1
chr5
88883328
89466398
+
MIR155HG
chr21
25561909
25575168
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.